Literature DB >> 10206951

Full peptide synthesis, purification, and characterization of six Tat variants. Differences observed between HIV-1 isolates from Africa and other continents.

J M Péloponèse1, Y Collette, C Grégoire, C Bailly, D Campèse, E F Meurs, D Olive, E P Loret.   

Abstract

AIDS in Africa is characterized by the equal distribution of mortality between the two genders because of highly virulent human immunodeficiency virus type 1 (HIV-1) strains. The viral protein Tat trans-activates viral gene expression and is essential for HIV-1 replication. We chemically synthesized six different Tat proteins, with sizes ranging from 86 to 101 residues, from HIV-1 isolates located in different parts of the world including highly virulent African strains. Protein purification, mass spectroscopy, and amino acid analysis showed that the synthesis was successful in each case but with different yields. We show that all have the ability to bind the HIV long terminal repeat (LTR) RNA trans-activation response element (TAR) region, involved in Tat-mediated trans-activation, but structural heterogeneities are revealed by circular dichroism. These Tat synthetic proteins cross membranes but differ in their ability to trans-activate an HIV LTR-reporter gene in stably transfected HeLa cells. Two Tat proteins from virulent African HIV-1 strains were much more active than those from Europe and the United States. The interferon-induced kinase (PKR), involved in cell antiviral defense, phosphorylates only Tat variants corresponding to less or nonvirulent HIV-1 isolates. Our results indicate that the high virulence of some African HIV-1 strains could be related to Tat activity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10206951     DOI: 10.1074/jbc.274.17.11473

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

Review 1.  Functional roles of HIV-1 Tat protein in the nucleus.

Authors:  Yana R Musinova; Eugene V Sheval; Carla Dib; Diego Germini; Yegor S Vassetzky
Journal:  Cell Mol Life Sci       Date:  2015-10-27       Impact factor: 9.261

2.  Differential induction of rat neuronal excitotoxic cell death by human immunodeficiency virus type 1 clade B and C tat proteins.

Authors:  Grant R Campbell; Jennifer D Watkins; Erwann P Loret; Stephen A Spector
Journal:  AIDS Res Hum Retroviruses       Date:  2010-12-07       Impact factor: 2.205

3.  Binding sites of the viral RNA element TAR and of TAR mutants for various peptide ligands, probed with LILBID: a new laser mass spectrometry.

Authors:  Nina Morgner; Hans-Dieter Barth; Bernhard Brutschy; Ute Scheffer; Sven Breitung; Michael Göbel
Journal:  J Am Soc Mass Spectrom       Date:  2008-07-03       Impact factor: 3.109

4.  Differential acetylation of Tat coordinates its interaction with the co-activators cyclin T1 and PCAF.

Authors:  Vanessa Brès; Hideaki Tagami; Jean-Marie Péloponèse; Erwan Loret; Kuan-Teh Jeang; Yoshihiro Nakatani; Stephane Emiliani; Monsef Benkirane; Rosemary E Kiernan
Journal:  EMBO J       Date:  2002-12-16       Impact factor: 11.598

5.  p53-derived host restriction of HIV-1 replication by protein kinase R-mediated Tat phosphorylation and inactivation.

Authors:  Cheol-Hee Yoon; Sang-Yoon Kim; Se Eun Byeon; Yideul Jeong; Jinjoo Lee; Kwang Pyo Kim; Jinseu Park; Yong-Soo Bae
Journal:  J Virol       Date:  2015-02-04       Impact factor: 5.103

6.  A monoclonal antibody directed against a conformational epitope of the HIV-1 trans-activator (Tat) protein neutralizes cross-clade.

Authors:  Sonia Mediouni; Jennifer D Watkins; Michel Pierres; Angélique Bole; Erwann P Loret; Gilbert Baillat
Journal:  J Biol Chem       Date:  2012-02-23       Impact factor: 5.157

7.  Human immunodeficiency virus type 1 subtype C Tat fails to induce intracellular calcium flux and induces reduced tumor necrosis factor production from monocytes.

Authors:  Grant R Campbell; Jennifer D Watkins; Kumud K Singh; Erwann P Loret; Stephen A Spector
Journal:  J Virol       Date:  2007-03-21       Impact factor: 5.103

8.  A naturally occurring substitution in human immunodeficiency virus Tat increases expression of the viral genome.

Authors:  Syed M Reza; Lin-Ming Shen; Rupa Mukhopadhyay; Mihaela Rosetti; Tsafi Pe'ery; Michael B Mathews
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

9.  Multimodality vaccination against clade C SHIV: partial protection against mucosal challenges with a heterologous tier 2 virus.

Authors:  Samir K Lakhashe; Siddappa N Byrareddy; Mingkui Zhou; Barbara C Bachler; Girish Hemashettar; Shiu-Lok Hu; Francois Villinger; James G Else; Shannon Stock; Sandra J Lee; Diego A Vargas-Inchaustegui; Egidio Brocca Cofano; Marjorie Robert-Guroff; Welkin E Johnson; Victoria R Polonis; Donald N Forthal; Erwann P Loret; Robert A Rasmussen; Ruth M Ruprecht
Journal:  Vaccine       Date:  2014-09-20       Impact factor: 3.641

10.  HIV-1 clade B Tat, but not clade C Tat, increases X4 HIV-1 entry into resting but not activated CD4+ T cells.

Authors:  Grant R Campbell; Erwann P Loret; Stephen A Spector
Journal:  J Biol Chem       Date:  2009-11-16       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.